R
Remo H.M. Furtado
Researcher at University of São Paulo
Publications - 68
Citations - 5110
Remo H.M. Furtado is an academic researcher from University of São Paulo. The author has contributed to research in topics: Medicine & Myocardial infarction. The author has an hindex of 14, co-authored 49 publications receiving 3121 citations. Previous affiliations of Remo H.M. Furtado include Brigham and Women's Hospital & Albert Einstein Hospital.
Papers
More filters
Journal ArticleDOI
Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial
Remo H.M. Furtado,Itamar Raz,Erica L. Goodrich,Sabina A. Murphy,Deepak L. Bhatt,Lawrence A. Leiter,Darren K. McGuire,John P.H. Wilding,Philip E. Aylward,Anthony J. Dalby,Mikael Dellborg,D. Dimulescu,Jose C. Nicolau,A.J. Oude Ophuis,Avivit Cahn,O Mosenzon,Ingrid Gause-Nilsson,Anna Maria Langkilde,Marc S. Sabatine,Stephen D. Wiviott +19 more
TL;DR: In patients with T2DM with or at high atherosclerotic cardiovascular disease risk, dapagliflozin reduced risk for hospitalization for heart failure and renal outcomes regardless of baselineSBP, with no difference in adverse events of interest at any level of baseline SBP.
Journal ArticleDOI
Influenza vaccination strategy in acute coronary syndromes: the vip-acs trial.
Henrique Andrade Rodrigues da Fonseca,Remo H.M. Furtado,André Zimerman,Pedro A Lemos,Marcelo Franken,Frederico Monfardini,Rodrigo P. Pedrosa,Rodrigo de Lemos S Patriota,L. C. S. Passos,F. T. C. Dall’Orto,Conrado R. Hoffmann Filho,Bruno Ramos Nascimento,Felipe Baldissera,Cesar A. C. Pereira,Paulo Caramori,Pedro Beraldo de Andrade,Carlos M. Esteves,Elke Ferreira Salim,Izabela Chave Pedro,Mariana Castaldi R Silva,Ewerton H De Pedri,Ana Carla R D Carioca,L. P. A. De Piano,C. S. N. Albuquerque,Diogo D.F. Moia,Roberta G. R. A. P. Momesso,Felipe P Machado,Lucas P. Damiani,Ronaldo V P Soares,Guilherme Schettino,Luiz Vicente Rizzo,Jose C. Nicolau,Otavio Berwanger +32 more
TL;DR: In this article , double-dose influenza vaccination during hospitalization for an acute coronary syndrome (ACS) compared with standard-dose outpatient vaccination (as recommended by current guidelines) would further reduce the risk of major cardiopulmonary events.
Journal ArticleDOI
Cardiology Training in Brazil and Developed Countries: Some Ideas for Improvement.
Lucas C. Godoy,Lucas C. Godoy,Michael E. Farkouh,Isabela C. K. Abud Manta,Talia Dalcoquio,Remo H.M. Furtado,Remo H.M. Furtado,Eric H.C. Yu,Carlos Gun,Jose C. Nicolau +9 more
TL;DR: The Brazilian cardiology training system is compared with other proposals implemented in developed countries from North America and Europe, aiming to point out issues worth of future discussion and factors such as training rotations and competencies, and program duration and distribution across the countries are presented.
Journal ArticleDOI
Dapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection
Hiddo J.L. Heerspink,Remo H.M. Furtado,Otavio Berwanger,Gary G. Koch,Felipe Martinez,Omar Mukhtar,Subodh Verma,Samvel B. Gasparyan,Fengming Tang,Sheryl L. Windsor,Vicente Ces de Souza-Dantas,Mildren Del Sueldo,Robert Frankel,Ali Javaheri,Rafael Maldonado,Caryn G. Morse,Marco A. Mota-Gomes,Douglas Shemin,Osvaldo Lourenço Silva,Alexandre Pereira Tognon,Marcel Twahirwa,Joan Buenconsejo,Russell Esterline,Jan Oscarsson,Phil Ambery,Anna Maria Langkilde,Mikhail Kosiborod +26 more
TL;DR: In patients hospitalized with COVID-19, treatment with dapagliflozin versus placebo resulted in numerically fewer participants who experienced organ failure or death, although these differences were not statistically significant.
Journal ArticleDOI
Effect of Evolocumab in Patients With Prior Percutaneous Coronary Intervention
Remo H.M. Furtado,Antonio Fagundes,Kazuma Oyama,Thomas A Zelniker,Minao Tang,Julia F Kuder,Sabina A. Murphy,Andrew Hamer,Hong Wang,Anthony C Keech,Robert P. Giugliano,Marc S. Sabatine,Brian A. Bergmark +12 more
TL;DR: Evolocumab reduces the risk of MACE in patients with prior PCI including the riskof coronary revascularization, with directionally consistent effects across several types ofRevascularization procedures, including coronary artery bypass grafting and PCI for stent or graft failure.